Fulminant fatal cardiotoxicity following cyclophosphamide therapy

Journal of Cardiology

Volumn 54, Issue 2, 2009, Pages 330-334

  Katayama, Minako ^a   Imai, Yukihiro ^b   Hashimoto, Hisako ^a   Kurata, Masayuki ^b   Nagai, Kenichi ^a   Tamita, Koichi ^b   Morioka, Shigefumi ^b   Furukawa, Yutaka ^b  

^a INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

Complications; Pathology; Pericarditis

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CATECHOLAMINE; CYCLOPHOSPHAMIDE; CYTARABINE; DIURETIC AGENT; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; RANIMUSTINE; VINCRISTINE;

ABDOMINAL MASS; ADULT; ARTICLE; AUTOPSY; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CARDIOTOXICITY; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FATIGUE; FULMINANT FATAL CARDIOTOXICITY; HEMOPERICARDIUM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LOW ENERGY RADIATION; MALE; MYOCARDITIS; PERICARDIAL EFFUSION; PERICARDITIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHYSICAL EXAMINATION; SIDE EFFECT; ST SEGMENT; SYSTOLIC DYSFUNCTION; URINE VOLUME; VASCULAR PATENCY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUTOPSY; CYCLOPHOSPHAMIDE; CYTARABINE; DRUG INTERACTIONS; DRUG-INDUCED LIVER INJURY; FATAL OUTCOME; HEART FAILURE; HUMANS; LIVER; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; MYOCARDIUM; PERICARDITIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

EID: 70349252134     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.01.006     Document Type: Article

References (8)

1. Goldberg M.A., Antin J.H., Guinan E.C., and Rappeport J.M. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 68 (1986) 1114-1118
2. Morandi P., Ruffini P.A., Benvenuto G.M., Raimondi R., and Fosser V. Cardiac toxicity of high-dose chemotherapy. Bone Marrow Transplant 35 (2005) 323-334
3. Floyd J.D., Nguyen D.T., Lobins R.L., Bashir Q., Doll D.C., and Perry M.C. Cardiotoxicity of cancer therapy. J Clin Oncol 23 (2005) 7685-7696
4. Steinherz L.J., Steinherz P.G., Mangiacasale D., O'Reilly R., Allen J., Sorell M., and Miller D.R. Cardiac changes with cyclophosphamide. Med Pediatr Oncol 9 (1981) 417-422
5. Gottdiener J.S., Appelbaum F.R., Ferrans V.J., Deisseroth A., and Ziegler J. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 141 (1981) 758-763
6. Birchall I.W., Lalani Z., Venner P., and Hugh J. Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy. Br J Radiol 73 (2000) 1112-1114
7. Tanoue K., Sanada J., Kayano T., Tanaka H., and Terashi T. Malignant lymphoma with various cardiac manifestations: a case report. J Cardiol 40 (2002) 117-123
8. Cardinale D., Sandri M.T., Martinoni A., Tricca A., Civelli M., Lamantia G., Cinieri S., Martinelli G., Cipolla C.M., and Fiorentini C. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol 36 (2000) 517-522